Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

V, Piechotta; C, Iannizzi; KL, Chai; SJ, Valk; C, Kimber; E, Dorando; I, Monsef; EM, Wood; AA, Lamikanra; DJ, Roberts; Z, McQuilten; C, So-Osman; LJ, Estcourt; N, Skoetz

doi:10.1002/14651858.cd013600.pub4

Public

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

Shared by NobleBlocks on May 20, 2021 • 12:00 AM UTC

Authors:

Piechotta V

Iannizzi C

Chai KL

Abstract

Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding benefits and r...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!